Hypoglycemia During Acute Illness in Children With Classic Congenital Adrenal Hyperplasia
Data from this paper was presented at the International Congress of Endocrinology (Lisbon, Portugal in September 2004) and the Pediatric Endocrine Nurses Society Conference (New Orleans, LA in May 2005).
published online 05 November 2008.
Congenital adrenal hyperplasia (CAH) describes a group of genetic, autosomal recessive conditions, where there is a block in cortisol biosynthesis. Approximately 95 percent of cases are due to 21-hydroxylase deficiency, which is discussed in this article. Patients with the severe or classic form of CAH have epinephrine deficiency in addition to cortisol deficiency. Both epinephrine and cortisol are important counterregulatory hormones and help prevent hypoglycemia during physical stress. This is the first prospective study to evaluate the incidence of hypoglycemia during acute illness in children with classic CAH. Our objective was to examine blood glucose levels and symptoms of these children during the physical stressor of a typical acute illness managed at home. Twenty patients, ages 3 to 10 years with classic CAH participated. Parents were instructed regarding management of illnesses, home blood glucose monitoring and questionnaire completion. Over 29 months, 20 patients completed questionnaires and 6 patients performed home blood glucose monitoring. A blood glucose of <60mg/dL was documented in 3 out of 8 monitored acute illness episodes, and in 2 out of 6 of monitored children. The acute illness episodes with documented blood glucose <60mg/dL were not associated with vomiting. Our data suggest that children with classic CAH may experience lowering of blood glucose during illnesses, and patient education regarding the management of common childhood illness should include glucose supplementation.
aReproductive Medicine and Biology Branch, National Institutes of Health, Bethesda, MD
bNational Institute of Child Health and Human Development, The National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD
Corresponding author: Margaret Keil, MS, CRNP.
This study was supported in part by the intramural program of NICHD, NIH and by the Congenital Adrenal hyperplasia Research, Education and Support (CARES) Foundation.
No commercial financial support to declare.
1 Commissioned Officers in the United States Public Health Service.